NSE/JBCHEPHARM (NSE/JBCHEPHARM)

National Stock Exchange of India: NSE/JBCHEPHARM · INR

₹2,416

+7.23 (+0.3%)· Recorded snapshot

Market cap	387.3B
Revenue (ttm)	41.5B
Net income (ttm)	7.1B
EPS (ttm)	₹44.5
P/E (trailing)	54.4x
P/E (forward)	43.0x
Dividend	₹22.0 (0.91%)
Volume	4,779,224
Beta	0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.5B
Net income (ttm): 7.1B
EPS (ttm): ₹44.5
P/E (trailing): 54.4x
P/E (forward): 43.0x
Market cap: 387.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E43

P25 n/aP50 n/aP75 n/a

Trailing P/E54.4

P25 n/aP50 n/aP75 n/a

ROE18.7

P25 n/aP50 n/aP75 n/a

ROIC22.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/JBCHEPHARM indicators

Market & fundamental data

Available fields

260

Groups with data

Currency

INR

Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	5,602
Employees change	298
Employees growth	5.62%
Enterprise value	INR 375.1B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	March
Founded	1976
Industry	Medical - Pharmaceuticals
Is primary listing	No
ISIN number	INE572A01036
Last earnings date	2026-05-11
Last refreshed	2026-10-28
Last stock split date	2023-09-18
Last stock split type	Forward
Market cap	INR 387.3B
Next earnings date	2026-11-06
Price	INR 2,416.10
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-07-16
Symbol	nse/JBCHEPHARM
Website	https://www.jbpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	52.67x
Average P/E ratio (10Y)	26.67x
Average P/E ratio (3Y)	43.39x
Average P/E ratio (5Y)	39.56x
Earnings yield	1.84%
EV/Earnings	52.87x
EV/EBIT	40.65x
EV/EBITDA	33.96x
EV/FCF	60.43x
EV/Sales	9.04x
FCF / EV yield	1.65%
FCF yield	1.6%
Forward P/E	43.05x
Graham number	508.305
Graham upside	-78.96%
Industry P/E	25.55x
Lynch fair value	INR 426.31
Lynch upside	-82.36%
P/(FCF - SBC) ratio	70.46x
P/(OCF - SBC) ratio	61.19x
P/B ratio	9.31x
P/E ratio	54.36x
P/FCF ratio	62.4x
P/OCF ratio	55.02x
P/S ratio	9.34x
Price / tangible book value	13.48x
Price/EBITDA ratio	35.51x
Sector forward P/E	36.5x
Sector P/E	46.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	22.25%
EBITDA margin	26.3%
Effective tax rate	25.5%
FCF margin	14.97%
Gross margin	67.77%
Operating margin	22.25%
Pretax margin	22.96%
Profit margin	17.1%
Profit per employee	INR 1.3M
Profitable quarters	37
Profitable years	22
Revenue per employee	INR 7.4M
ROA	12.48%
ROA (5Y)	12.44%
ROCE	21.08%
ROE	18.69%
ROE (5Y)	19.44%
ROIC	22.2%
ROIC (5Y)	20.88%
SBC / revenue	1.71%
Tax / revenue	5.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.95%
EPS growth (Q)	-31.02%
EPS growth (QoQ)	-49.21%
EPS growth 10Y	28.26%
EPS growth 3Y	19.31%
EPS growth 5Y	8.93%
EPS growth years	4
FCF growth	-22.88%
FCF growth 3Y	3.73%
FCF growth 5Y	18.38%
Gross profit growth	9.65%
Gross profit growth (Q)	-0.1%
Gross profit growth 3Y	12.9%
Gross profit growth 5Y	16.32%
Net income growth	7.56%
Net income growth (Q)	-30.42%
Net income growth (QoQ)	-48.77%
Net income growth 3Y	20.07%
Net income growth 5Y	9.63%
Net income growth years	4
OCF growth	-22%
OCF growth 10Y	36.93%
OCF growth 3Y	3.84%
OCF growth 5Y	17.46%
Operating income growth	7.3%
Operating income growth (Q)	-16.88%
Operating income growth 3Y	15.96%
Operating income growth 5Y	13.52%
Revenue growth	5.87%
Revenue growth (Q)	-4.77%
Revenue growth (QoQ)	-15.07%
Revenue growth 10Y	22.84%
Revenue growth 3Y	9.61%
Revenue growth 5Y	15.22%
Revenue growth quarters	22
Revenue growth years	14

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -831.9M
Depreciation and amortization	INR 1.7B
EBIT	INR 9.2B
EBITDA	INR 10.9B
EPS	INR 44.45
Financing cash flow	INR -1.2B
Free cash flow	INR 6.2B
Free cash flow minus SBC	INR 5.5B
Gross profit	INR 28.1B
Income taxes	INR 2.4B
Investing cash flow	INR -5.9B
Net borrowing	INR -387.2M
Net cash flow	INR -49.1M
Net income	INR 7.1B
Operating cash flow minus SBC	INR 6.3B
Operating income	INR 9.2B
Revenue	INR 41.5B
Stock-based compensation	INR 710.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	23.55
Book value per share	INR 259.05
Debt / EBITDA	0
Debt / equity	0
Debt / FCF	0.01
Goodwill	INR 574.6M
Interest coverage	185.45
Long-term assets	INR 20.6B
Long-term liabilities	INR 2.2B
Net cash (debt)	INR 12.2B
Net cash / market cap	3.14%
Net cash growth	188.43%
Net debt / EBITDA	-1.12
Net debt / equity	-0.29
Net debt / FCF	-1.96
Piotroski F-Score	5
Property, plant and equipment	INR 6.7B
Shareholders' equity	INR 41.6B
Tangible book value	INR 28.7B
Tangible book value per share	INR 178.92
Total assets	INR 49.7B
Total cash	INR 12.2B
Total debt	INR 35.9M
Total liabilities	INR 8.1B
WACC	4.34%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.9
Current assets	INR 29.1B
Current liabilities	INR 5.9B
Current ratio	4.92
Inventory turnover	2.21
Net working capital	INR 11B
Quick ratio	3.45
Working capital	INR 23.2B
Working capital turnover	2.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.59%
Dividend growth	41.94%
Dividend growth (10Y)	9.05%
Dividend growth (3Y)	35.34%
Dividend growth (5Y)	21.67%
Dividend growth years	3
Dividend payment date	2026-07-17
Dividend payment years	24
Dividend payout frequency	Semi-Annual
Dividend per share	INR 22.00
Dividend yield	0.91%
Ex-dividend date	2026-05-29
Last dividend	INR 9.30
Payout ratio	44.16%
Shareholder yield	0.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,740.84%
10Y return CAGR	35.18%
10Y total return	1,936.12%
150-day SMA	INR 2,046.41
15Y price change	3,338.07%
15Y return CAGR	31.48%
15Y total return	5,963.67%
1D price change	0.3%
1M price change	8.94%
1M total return	8.94%
1W price change	-0.81%
1W total return	-0.81%
1Y price change	46.42%
1Y return CAGR	48.64%
1Y total return	48.6%
20-day SMA	INR 2,344.43
200-day SMA	INR 1,965.88
20Y price change	5,419.36%
20Y return CAGR	26.38%
20Y total return	10,694.37%
3M price change	21.96%
3M total return	22.47%
3Y price change	88.09%
3Y return CAGR	24.68%
3Y total return	93.83%
50-day SMA	INR 2,241.52
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,525.50
52-week high date	2026-07-16
52-week low	INR 1,638.50
52-week low date	2025-09-26
5Y price change	168.01%
5Y return CAGR	22.99%
5Y total return	181.4%
6M price change	27.47%
6M total return	28.86%
All-time high	INR 2,525.50
All-time high date	2026-07-16
All-time low	INR 12.75
All-time low date	2008-10-08
Average true range (ATR)	INR 59.79
Average volume	637.3K
Beta (5Y)	0.02
Change from 52-week high	-4.33%
Change from 52-week low	47.46%
Change from all-time high	-4.33%
Change from all-time low	18,849.8%
Change from open	-3.59%
Day's gap	4.03%
Dollar volume	INR 11.5B
High price	INR 2,525.50
Low price	INR 2,380.00
Monthly RSI	77.8
Open price	INR 2,506.00
Position in 52-week range	24.81%
Previous close	INR 2,408.90
Price vs 150-day SMA	18.07%
Price vs 20-day SMA	3.06%
Price vs 200-day SMA	22.9%
Price vs 50-day SMA	7.79%
Relative volume	7.5
RSI	61.53
Sharpe ratio	1.91
Sharpe ratio (3Y)	0.9
Sharpe ratio (5Y)	0.85
Sortino ratio	3.55
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.56
Volume	4.8M
Weekly RSI	72.87
YTD price change	32.78%
YTD total return	34.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81.6M
Shares change (QoQ)	0.91%
Shares change (YoY)	0.59%
Shares held by insiders	0.05%
Shares held by institutions	20.77%

Deeper analysis on NSE/JBCHEPHARM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/JBCHEPHARM report

Is a complete NSE/JBCHEPHARM research report available?

No complete published report is available for nse/JBCHEPHARM (NSE/JBCHEPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/JBCHEPHARM (NSE/JBCHEPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/JBCHEPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/JBCHEPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/JBCHEPHARM

Frequently asked questions